Author

Torben Skovsgaard

Observed names: SKOVSGAARD T., T SKOVSGAARD, T Skovsgaard, T. SKOVSGAARD, T. Skovsgaard

Institutions: University of Copenhagen, University of Padua, Herlev Hospital, Hvidovre Hospital

Observed institutions: University of Copenhagen, Jagiellonian University, Karolinska University Hospital, University of Padua, University of Oslo, Helsinki University Hospital, University Hospital of Bern, Herlev Hospital, Bispebjerg Hospital, Hvidovre Hospital, Copenhagen University Hospital, Gentofte Hospital, Princess Margaret Cancer Centre, Rigshospitalet, Copenhagen Municipal Hospital, Regionshospitalet Viborg, Næstved Sygehus, European Organisation for Research and Treatment of Cancer

OpenAlex ID: A5111908766

Functional monitoring of anthracycline cardiotoxicity:a prospective, blinded, long-term observational study of outcome in 120 patients

2002 · B.V. Jensen, T. Skovsgaard, et al. · Annals of Oncology · 340

PDF

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.

1998 · M Ryberg, D Nielsen, et al. · Journal of Clinical Oncology · 289

Randomized Comparative Study of Tegafur/Uracil and Oral Leucovorin Versus Parenteral Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer

2002 · James Carmichael, Tadeusz Popiela, et al. · Journal of Clinical Oncology · 271

Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells.

1978 · T Skovsgaard · PubMed · 266

In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution

1999 · Julie Gehl, Thyge H. Sørensen, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 251

Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells.

1978 · T Skovsgaard · PubMed · 232

Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery

2002 · Julie Gehl, Torben Skovsgaard, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 230

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

2002 · Cornelis JA Punt, Attila Nagy, et al. · The Lancet · 214

Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs

1998 · Julie Gehl, Torben Skovsgaard, et al. · Anti-Cancer Drugs · 213

New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients

2008 · Marianne Ryberg, Dorte Nielsen, et al. · JNCI Journal of the National Cancer Institute · 180

Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity

1997 · Thomas Litman, Thomas Zeuthen, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 180

PDF

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

2003 · K Dalhoff, J Dancey, et al. · British Journal of Cancer · 175

PDF

Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

1977 · Torben Skovsgaard · Biochemical Pharmacology · 169

Cellular resistance to anthracyclines

1996 · Dorte Nielsen, Christian Maare, et al. · General Pharmacology The Vascular System · 167

Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity.

1997 · Thomas Litman, Thomas Zeuthen, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 166

PDF

P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines

1992 · Dorte Nielsen, Torben Skovsgaard · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 155

Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2

2002 · Thomas Litman, Ulla Jensen, et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 131

PDF

Membrane transport of anthracyclines

1982 · T SKOVSGAARD, N NISSEN · Pharmacology & Therapeutics · 122

Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

1978 · Torben Skovsgaard · Biochemical Pharmacology · 121

Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies

2008 · Jens Benn Sorensen, Torben Skovsgaard, et al. · Cancer · 87

PDF

Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy

1996 · B.V Jensen, T Skovsgaard, et al. · The Lancet · 87

PDF

Increase in Nonspecific Adsorptive Endocytosis in Anthracycline-and Vinca Alkaloid-Resistant Ehrlich Ascites Tumor Cell Lines2

1987 · Maxwell Sehested, Torben Skovsgaard, et al. · JNCI Journal of the National Cancer Institute · 86

Angiotensin converting enzyme inhibitors for cancer treatment?

2004 · Dorte Nielsen, Benny Jensen, et al. · Acta Oncologica · 79

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil

1987 · M Sehested, T Skovsgaard, et al. · British Journal of Cancer · 78

PDF

Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study

2000 · Dorte Nielsen, Per Dombernowsky, et al. · Cancer Chemotherapy and Pharmacology · 72

Works count: 103

Citation count: 5,683

H-index: 37

I10-index: 68